The influence of Helicobacter pylori infection on the prevalence of endoscopic erosive esophagitis

Helicobacter

Volumn 11, Issue 6, 2006, Pages 556-561

  Unal, Selahattin ^a   Karakan, Tarkan ^a   Dogan, Ibrahim ^a   Cindoruk, Mehmet ^a   Dumlu, Sukru ^a  

^a GAZI UNIVERSITY   (Turkey)

Author keywords

Erosive esophagitis; Gastroesophageal reflux disease; Helicobacter pylori; Prevalence

Indexed keywords

UREASE;

ADULT; AGED; ARTICLE; CORRELATION ANALYSIS; EROSION; ESOPHAGOGASTRODUODENOSCOPY; HELICOBACTER INFECTION; HELICOBACTER PYLORI; HIATUS HERNIA; HUMAN; HUMAN TISSUE; MAJOR CLINICAL STUDY; MALE; NONHUMAN; PREVALENCE; PRIORITY JOURNAL; REFLUX ESOPHAGITIS; RETROSPECTIVE STUDY; RISK REDUCTION; TIME SERIES ANALYSIS; ULCER;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; BIOPSY; ESOPHAGITIS; ESOPHAGUS; FEMALE; HELICOBACTER INFECTIONS; HUMANS; MALE; MEDICAL RECORDS SYSTEMS, COMPUTERIZED; MIDDLE AGED; PREVALENCE; RETROSPECTIVE STUDIES; TURKEY; ULCER; UNIVERSITIES; UREASE;

HELICOBACTER PYLORI;

EID: 33750561482     PISSN: 10834389     EISSN: 15235378     Source Type: Journal    
DOI: 10.1111/j.1523-5378.2006.00458.x     Document Type: Article

References (39)

1. O'Connor HJ. Review article. Helicobacter pylori and gastrooesophageal reflux disease - clinical implications and management. Aliment Pharmacol Ther 1999;13:1-11.
2. Schenk BE, Kuipers EJ, Klinkenberg-Knol EC, et al. Helicobacter pylori and the efficacy of omeprazole therapy for gastroesophageal reflux disease. Am J Gastroenterol 1999;94:884-7.
3. Wu JC, Sung JJ, Chan FK, et al. Helicobacter pylori infection is associated with milder gastro-oesophageal reflux disease. Aliment Pharmacol Ther 2000;14:427-32.
4. Loffeld RJ, Werdmuller BF, Kuster JG, et al. Colonization with cagA-positive Helicobacter pylori strains inversely associated with reflux esophagitis and Barrett's esophagus. Digestion 2000;62:95-9.
5. Arents NL, van Zwet AA, Thijs JC, et al. The importance of vacA, cagA, and iceA genotypes of Helicobacter pylori infection in peptic ulcer disease and gastroesophageal reflux disease. Am J Gastroenterol 2001;96:2603-8.
6. Queiroz DM, Guerra JB, Rocha GA, et al. IL1B and IL1RN polymorphic genes and Helicobacter pylori cagA strains decrease the risk of reflux esophagitis. Gastroenterology 2004;127:73-9.
7. Raghunath A, Hungin AP, Wooff D, Childs S. Prevalence of Helicobacter pylori in patients with gastro-oesophageal reflux disease: systematic review. BMJ 2003;326:737.
8. Locke G, Talley N, Fett S, et al. Prevalence and clinical spectrum of gastroesophageal reflux: a population-based study in Olmsted County. Minn Gastroenterol 1997;112:1448-56.
9. Goh KL. Gastro-oesophageal reflux disease in Asia. J Gastroenterol Hepatol 2000;15:230-8.
10. Wong WM, Lam SK, Hui WM, et al. Long-term prospective follow-up of endoscopic oesophagitis in southern Chinese - prevalence and spectrum of the disease. Aliment Pharmacol Ther 2002;16:2037-42.
11. Malfertheiner P, O'Connor HJ, Genta RM, et al. Symposium: Helicobacter pylori and clinical risks - focus on gastro-oesophageal reflux disease. Aliment Pharmacol Ther 2002;16:1-10.
12. Vakil N, Hahn B, McSorley D. Recurrent symptoms and gastro-oesophageal reflux disease in patients with duodenal ulcer treated for Helicobacter pylori infection. Aliment Pharmacol Ther 2000;14:45-51.
13. Laine L, Sugg J. Effect of Helicobacter pylori eradication on development of erosive esophagitis and gastroesophageal reflux disease symptoms: a post-hoc analysis of eight double-blind prospective studies. Am J Gastroenterol 2002;97:2992-7.
14. Laine L, Dhir V. Helicobacter pylori eradication does not worsen quality of life related to reflux symptoms: a prospective trial. Aliment Pharmacol Ther 2002;16:1143-8.
15. Kiltz U, Pfaffenbach B, Schmidt WE, Adamek RJ. The lack of influence of CagA-positive Helicobacter pylori strains on gastro-oesophageal reflux disease. Eur J Gastroenterol Hepatol 2002;14:979-84.
16. Leodolter A, Wolle K, Peitz U, et al. Helicobacter pylori genotypes and expression of gastritis in erosive gastro-oesophageal reflux disease. Scand J Gastroenterol 2003;38:498-502.
17. Malfertheiner P, Dent J, Zeijlon L, et al. Impact of Helicobacter pylori eradication on heartburn in patients with gastric or duodenal ulcer disease - results from a randomized trial programme. Aliment Pharmacol Ther 2002;16:1431-42.
18. Ishiki K, Mizuno M, Take S, et al. Helicobacter pylori eradication improves pre-existing reflux esophagitis in patients with duodenal ulcer disease. Clin Gastroenterol Hepatol 2004;2:474-9.
19. Covacci A, Telford JL, Del Giudice G, et al. Helicobacter pylori virulence and genetic geography. Science 1999;284:1328-33.
20. Ando T, El-Omar EM, Goto Y, et al. Interleukin 1B proinflammatory genotypes protect against gastro-oesophageal reflux disease through induction of corpus atrophy. Gut 2006;55:158-64.
21. Muramatsu A, Azuma T, Okuda T, et al. Association between interleukin 1b-511C/T polymorphism and reflux esophagitis. Jpn J Gastroenterol 2005;40:873-7.
22. McClave SA, Boyce HW, Gottfried MR. Early diagnosis of columnar lined esophagus: a new endoscopic criterion. Gastrointest Endosc 1987;33:413-6.
23. Spechler SJ, Goyal RK. Barrett's esophagus. N Engl J Med 1986;315:362-71.
24. Lundell LR, Dent J, Bennett JR, et al. Endoscopic assessment of oesophagitis: clinical and functional correlates and further validation of the Los Angeles classification. Gut 1999;45:172-80.
25. Cohen H, Laine L. Endoscopic methods for the diagnosis of Helicobacter pylori. Aliment Pharmacol Ther 1997;11:3-9.
26. Ho KY, Chan YH, Kang JY. Increasing trend of reflux esophagitis and decreasing trend of Helicobacter pylori infection in patients from a multiethnic Asian country. Am J Gastroenterol 2005;100:1923-8.
27. Yeh C, Hsu CT, Ho AS, et al. Erosive esophagitis and Barrett's esophagus in Taiwan: a higher frequency than expected. Dig Dis Sci 1997;42:702-6.
28. Wu JC, Sung JJ, Chan FK, et al. Helicobacter pylori infection is associated with milder gastro-oesophageal reflux disease. Aliment Pharmacol Ther 2000;14:427-32.
29. Warburton-Timms VJ, Charlett A, Valori RM, et al. The significance of cagA+ Helicobacter pylori in reflux oesophagitis. Gut 2001;49:341-6.
30. Loffeld RJ, Ten Tije BJ, Arends JW. Prevalence and significance of Helicobacter pylori in patients with Barrett's esophagus. Am J Gastroenterol 1992;87:1598-600.
31. Vicari JJ, Peek RM, Falk GW, et al. The seroprevalence of CagA-positive Helicobacter pylori strains in the spectrum of gastroesophageal reflux disease. Gastroenterology 1998;115:50-7.
32. Loffeld RJ. H. pylori and reflux esophagitis in Turkish patients living in the Zaanstreek region in the Netherlands. Dig Dis Sci 2003;48:1846-9.
33. Simsek H, Balaban YH, Gunes DD, et al. Alarming clarithromycin resistance of Helicobacter pylori in Turkish population. Helicobacter 2005;10:360-1.
34. Frank JR, Clemens J. Helicobacter in the developing world. Microbes Infect 2003;5:705-13.
35. Gisbert JP, Pajares JM. Prevalence of Helicobacter pylori infection in gastroesophageal reflux disease and Barrett's esophagus. Med Clin (Barc) 2002;119:217-23.
36. Goldblum JR, Richter JE, Vaezi M, et al. Helicobacter pylori infection not gastroesophageal reflux is the major cause of inflammation and intestinal metaplasia of gastric cardiac mucosa. Am J Gastroenterol 2002;97:302-11.
37. Ferrandez A, Benito R, Arenas J, et al. CagA-positive Helicobacter pylori infection is not associated with decreased risk of Barrett's esophagus in a population with high H. pylori infection rate. BMC Gastroenterol 2006;16:7.
38. Aydin F, Kaklikkaya N, Ozgur O, et al. Distribution of vacA alleles and cagA status of Helicobacter pylori in peptic ulcer disease and non-ulcer dyspepsia. Clin Microbiol Infect 2004;10:1102-4.
39. Labenz J, Jaspersen D, Kulig M, et al. Risk factors for erosive esophagitis: a multivariate analysis based on the ProGERD study initiative. Am J Gastroenterol 2004;99:1652-6.